Quarterly report pursuant to Section 13 or 15(d)

3. Research and Development Expenses

3. Research and Development Expenses
6 Months Ended
Sep. 30, 2017
Research and Development [Abstract]  
Research and Development Expenses

Our research and development costs are expensed as incurred. We incurred research and development expenses during the three and six month periods ended September 30, 2017 and 2016, which are included in various operating expense line items in the accompanying condensed consolidated statements of operations. Our research and development expenses in those periods were as follows:


      September 30,     September 30,  
      2017     2016  
  Three months ended     $ 168,570     $ 280,860  
  Six months ended     $ 333,433     $ 377,843